These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12109969)

  • 41. Use of novel antipsychotic drugs.
    Raleigh F
    Pharmacotherapy; 1996; 16(6 Pt 2):160S-165S; discussion 166S-168S. PubMed ID: 8948000
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Two cases of quetiapine augmentation for donepezil-refractory visual hallucinations in dementia with Lewy bodies.
    Terao T; Shimomura T; Izumi Y; Nakamura J
    J Clin Psychiatry; 2003 Dec; 64(12):1520-1. PubMed ID: 14728121
    [No Abstract]   [Full Text] [Related]  

  • 43. Donepezil for Alzheimer's disease.
    Benjamin B; Burns A
    Expert Rev Neurother; 2007 Oct; 7(10):1243-9. PubMed ID: 17939763
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Drug-induced extrapyramidal reactions.
    Teoh L; Allen H; Kowalenko N
    J Paediatr Child Health; 2002 Feb; 38(1):95-7. PubMed ID: 11869410
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Subgroup analysis of US and non-US patients in a global study of high-dose donepezil (23 mg) in moderate and severe Alzheimer's disease.
    Salloway S; Mintzer J; Cummings JL; Geldmacher D; Sun Y; Yardley J; Mackell J
    Am J Alzheimers Dis Other Demen; 2012 Sep; 27(6):421-32. PubMed ID: 22930699
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacological treatment of cognitive deficits in Alzheimer's disease.
    Lam W
    Med J Aust; 2002 Mar; 176(6):297; author reply 297-8. PubMed ID: 11999269
    [No Abstract]   [Full Text] [Related]  

  • 47. Efficacy and safety of donepezil over 3 years: an open-label, multicentre study in patients with Alzheimer's disease.
    Burns A; Gauthier S; Perdomo C
    Int J Geriatr Psychiatry; 2007 Aug; 22(8):806-12. PubMed ID: 17199235
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Featured CME topic: dementia. Medication update.
    Slagle MA
    South Med J; 2001 Jul; 94(7):678-81. PubMed ID: 11531174
    [No Abstract]   [Full Text] [Related]  

  • 49. Donepezil treatment of patients with severe Alzheimer's disease in a Japanese population: results from a 24-week, double-blind, placebo-controlled, randomized trial.
    Homma A; Imai Y; Tago H; Asada T; Shigeta M; Iwamoto T; Takita M; Arimoto I; Koma H; Ohbayashi T
    Dement Geriatr Cogn Disord; 2008; 25(5):399-407. PubMed ID: 18391486
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Challenges in the management of delirium: a case of augmentation with donepezil following inadequate response and adverse effects with risperidone.
    Stocker L; Jellestad L; Jenewein J; Boettger S
    Psychiatr Danub; 2015 Mar; 27(1):64-6. PubMed ID: 25751433
    [No Abstract]   [Full Text] [Related]  

  • 51. Donepezil-induced jaw tremor.
    Song IU; Kim JS; Ryu SY; Lee SB; An JY; Lee KS
    Parkinsonism Relat Disord; 2008 Nov; 14(7):584-5. PubMed ID: 18321753
    [No Abstract]   [Full Text] [Related]  

  • 52. Donepezil in Alzheimer's disease: a clinical observational study evaluating individual treatment response.
    Riepe MW; Kohler J; Horn R
    Curr Med Res Opin; 2007 Aug; 23(8):1829-35. PubMed ID: 17599785
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Donepezil and vitamin E for mild cognitive impairment.
    Ownby RL
    Curr Psychiatry Rep; 2006 Feb; 8(1):9. PubMed ID: 16513036
    [No Abstract]   [Full Text] [Related]  

  • 54. Preliminary communication: urodynamic assessment of donepezil hydrochloride in patients with Alzheimer's disease.
    Sakakibara R; Uchiyama T; Yoshiyama M; Yamanishi T; Hattori T
    Neurourol Urodyn; 2005; 24(3):273-5. PubMed ID: 15605367
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Taste-masked and affordable donepezil hydrochloride orally disintegrating tablet as promising solution for non-compliance in Alzheimer's disease patients.
    Liew KB; Tan YT; Peh KK
    Drug Dev Ind Pharm; 2015 Apr; 41(4):583-93. PubMed ID: 24495273
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relation between cholinesterase inhibitor and Pisa syndrome.
    Kwak YT; Han IW; Baik J; Koo MS
    Lancet; 2000 Jun; 355(9222):2222. PubMed ID: 10881902
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mania associated with donepezil.
    Benazzi F
    Int J Geriatr Psychiatry; 1998 Nov; 13(11):814-5. PubMed ID: 9850879
    [No Abstract]   [Full Text] [Related]  

  • 58. Combination of the phosphodiesterase 10A inhibitor, MR1916 with risperidone shows additive antipsychotic-like effects without affecting cognitive enhancement and cataleptic effects in rats.
    Arakawa K; Maehara S
    Neuropsychopharmacol Rep; 2020 Jun; 40(2):190-195. PubMed ID: 32351052
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rabbit syndrome induced by combined lithium and risperidone.
    Mendhekar DN
    Can J Psychiatry; 2005 May; 50(6):369. PubMed ID: 15999955
    [No Abstract]   [Full Text] [Related]  

  • 60. The effects of donepezil and neostigmine in a patient with unusual pseudocholinesterase activity.
    Sprung J; Castellani WJ; Srinivasan V; Udayashankar S
    Anesth Analg; 1998 Nov; 87(5):1203-5. PubMed ID: 9806710
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.